Presentations of stroke and acute myocardial infarction in the first 28 days following the introduction of State of Emergency restrictions for COVID‐19

EMA - Emergency Medicine Australasia - Tập 32 Số 6 - Trang 1040-1045 - 2020
Biswadev Mitra1,2,3, Rob Mitchell1,3, Geoffrey Cloud4,5, Dion Stub6,7,3, Minh Nguyen5, Shane Nanayakkara6,7, Jean‐Philippe Miller1, Gerard O’Reilly1,2,3, De Villiers Smit1,2,3, Peter Cameron1,2,3
1Emergency and Trauma Centre, The Alfred Hospital, Melbourne, Victoria, Australia.
2National Trauma Research Institute, The Alfred Hospital, Melbourne, Victoria, Australia
3School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
4Department of Clinical Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia
5Stroke Services, The Alfred Hospital, Melbourne, Victoria, Australia
6Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia
7Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia

Tóm tắt

SOE measures to achieve physical distancing and restrict community contact were not associated with significant changes in time to ED presentation after acute stroke and AMI. Time to initial investigation and life‐saving interventions were also unchanged in the first 28 days. Public health messaging encouraging patients with acute illness or injury to seek medical assessment should be continued.

Từ khóa


Tài liệu tham khảo

10.1016/S2468-2667(20)30073-6

10.1016/S1473-3099(20)30162-6

Milne GJ, 2020, The effectiveness of social distancing in mitigating COVID‐19 spread: a modelling analysis, medRxiv

10.1111/1742-6723.13606

Levine GN, 2015, ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST‐elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST‐elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, Catheter. Cardiovasc. Interv., 87, 1001

10.1016/S0140-6736(10)60491-6

10.1016/S0140-6736(15)00391-8

10.1111/1742-6723.13513

10.5694/mja13.00235

10.1159/000507666

10.1016/j.jacc.2020.04.011

Zitelny E, 2020, STEMI during the COVID‐19 pandemic – an evaluation of incidence, Cardiovasc. Pathol., 48, 107232, 10.1016/j.carpath.2020.107232

10.1007/s10072-020-04375-9

10.1161/CIRCOUTCOMES.120.006631

Rodríguez‐Leor O, 2020, Impacto de la pandemia de COVID‐19 sobre la actividad asistencial en cardiología intervencionista en España, REC Interv. Cardiol., 2, 82

10.1007/s00134-020-05993-9

10.1016/j.jacc.2020.03.021

Abdelaziz HK, 2020, COVID‐19 pandemic and acute myocardial infarction: management protocol from a British Cardiac Centre, Crit. Pathw. Cardiol., 19, 55, 10.1097/HPC.0000000000000222

10.1161/STROKEAHA.120.029838

10.1016/j.annemergmed.2004.11.011

10.1093/ehjqcco/qcaa038

10.1111/1742-6723.13558

10.3201/eid2203.150977

10.1016/S0140-6736(20)30895-3

10.1136/bmj.m1557